|Articles|December 1, 2018
- Pharmaceutical Executive-12-01-2018
- Volume 38
- Issue 12
Pharmaceutical Executive, December 2018 Issue (PDF)
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Science & Finance: The Biotech Blendover 7 years ago
Europe’s Digital Health Path Still at a Crossroadsover 7 years ago
Lessons for Pharma from the Merck Cyber Attackover 7 years ago
Securing a Winning Strategy for Real-World Evidenceover 7 years ago
RWE: Answering Questions in Rare Diseaseover 7 years ago
Measuring the Probability of Pricing and Access Successover 7 years ago
Four Challenges for AI in the Life Sciencesover 7 years ago
Country Report: MalaysiaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
3
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5